Neptune krill oil gains Health Canada claims

By Lorraine Heller

- Last updated on GMT

Related tags: Atherosclerosis, Health canada

Health Canada has approved health claims for Neptune’s krill oil ingredient, linking it to heart health, women’s health and inflammation benefits.

According to the Canadian company, the therapeutic and risk reduction claims follow two years of review of its safety and clinical research data and will help to reinforce its position in the krill market.

“The NKO approved claims are competitive when compared to the already approved claims for fish oils since not only have they been accepted at significantly much lower doses, but they also offer more specific health benefits in cardiovascular, joint and women health,”​ said André Godin, CFO of Neptune Technologies & Bioressources.

NeptuneKrill Oil (NKO), a lipid derived from the planktonic family of crustacean, is rich in omega-3 as well as phospholipids and antioxidants. It was originally launched at the end of 2003 for the North American supplements market, where it has already established a strong presence.

NKO health claims

The approved claims are:

  1. Cardiovascular health:
  • Helps to reduce the levels of LDL cholesterol (in conjunction with conventional statin therapy): 2 softgels (1g) per day
  • Helps to increase the levels of HDL cholesterol (in conjunction with conventional statin therapy): 2 softgels (1g) per day
  • Helps to reduce the levels of triglycerides (in conjunction with conventional statin therapy): 4 softgels (2g) per day

2. Inflammation:

  • Helps to reduce C-reactive protein levels, a clinical marker of inflammation: 1 softgel (0.5g) per day
  • Helps to reduce pain associated with osteoarthritis: 1 softgel (0.5g) per day

3. Women’s Health:

  • Helps to relieve symptoms of premenstrual syndrome (PMS): 4 softgels (2g) per day
  • Helps to relieve symptoms of dysmenorrhea: 4 softgels (2g) per day

To view a full list of the approved claims, click here​.

Omega-3 claims

In June 2009 Health Canada approved health claims for omega-3, including a claim that products providing 1g - 3g EPA and DHA, per day help to reduce serum triglycerides.

Dr Wael Massrieh, Neptune director of R & D explained that this is equivalent to 3-10g of fish oil per day, or 6-20 softgels, compared to four NKO softgels recently approved for the same indication.

He added that “contrary to fish oil, Health Canada approved a stronger claim for NKO for cholesterol with a decrease of LDL (bad cholesterol) and increase of HDL (good cholesterol) using only two softgels per day as well as an anti-inflammatory claim using only one softgel per day and a specific claim for premenstrual syndrome (PMS).”

Related news

Show more

Related products

show more

Pycnogenol® Improves Fitness and Muscle Recovery

Pycnogenol® Improves Fitness and Muscle Recovery

Horphag Research | 29-Jun-2020 | Clinical Study

Published studies show daily supplementation of Pycnogenol® is effective in boosting muscle performance, increasing endurance and reducing cramping and...

DHA ORIGINS™: The sustainable potential of algae.

DHA ORIGINS™: The sustainable potential of algae.

Fermentalg | 22-Jun-2020 | Technical / White Paper

Consumers find out about nutritional quality by closely scrutinizing the labeling and list of ingredients (clean label). They are interested in the provenance...

Optimal Cardiovascular Health Requires Vitamin K2

Optimal Cardiovascular Health Requires Vitamin K2

NattoPharma USA, Inc. | 15-Jun-2020 | Technical / White Paper

In these trying times, general health and basic nutrition are more important than ever. New research now punctuates the importance of securing this healthy...

Learn About dicentra’s Clinical Trial Services

Learn About dicentra’s Clinical Trial Services

dicentra – CRO and regulatory consulting firm | 10-Jun-2020 | Product Brochure

Learn about our people, our location, and our technology to discover why dicentra CRO is the best choice for your next research needs.

Related suppliers

Follow us

Products

View more

Webinars